Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.170
-0.060 (-4.88%)
At close: Mar 27, 2026, 4:00 PM EDT
1.160
-0.010 (-0.85%)
After-hours: Mar 27, 2026, 6:36 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $72.44 million as of March 27, 2026. Its market cap has decreased by -22.17% in one year.
Market Cap
72.44M
Enterprise Value
-89.40M
1-Year Change
-22.17%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $72.44M, a decrease of -90.18%. That is a compound annual growth rate of -32.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 72.44M | -3.37% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeurAxis | 77.19M |
| Pelthos Therapeutics | 75.47M |
| Verrica Pharmaceuticals | 75.24M |
| Cingulate | 74.31M |
| aTyr Pharma | 73.73M |
| NRx Pharmaceuticals | 72.42M |
| Grace Therapeutics | 72.26M |
| Fractyl Health | 71.17M |